Precipio PE Ratio 2010-2024 | PRPO

Current and historical p/e ratio for Precipio (PRPO) from 2010 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Precipio PE ratio as of November 20, 2024 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Precipio PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2024-11-19 6.14 0.00
2024-09-30 6.70 $-1.83 0.00
2024-06-30 5.19 $-2.45 0.00
2024-03-31 6.70 $-3.42 0.00
2023-12-31 6.50 $-4.56 0.00
2023-09-30 5.61 $-7.44 0.00
2023-06-30 7.80 $-9.20 0.00
2023-03-31 13.28 $-9.20 0.00
2022-12-31 11.03 $-10.60 0.00
2022-09-30 16.08 $-10.40 0.00
2022-06-30 21.20 $-9.20 0.00
2022-03-31 27.00 $-10.20 0.00
2021-12-31 31.60 $-7.80 0.00
2021-09-30 56.40 $-6.00 0.00
2021-06-30 72.60 $-8.60 0.00
2021-03-31 46.20 $-9.80 0.00
2020-12-31 41.40 $-23.80 0.00
2020-09-30 49.00 $-33.40 0.00
2020-06-30 28.40 $-35.40 0.00
2020-03-31 14.00 $-52.40 0.00
2019-12-31 41.00 $-46.40 0.00
2019-09-30 52.20 $-105.80 0.00
2019-06-30 67.60 $-150.58 0.00
2019-03-31 37.50 $-174.55 0.00
2018-12-31 46.20 $-305.88 0.00
2018-09-30 118.56 $-236.88 0.00
2018-06-30 110.34 $-593.70 0.00
2018-03-31 161.16 $-5,151.43 0.00
2017-12-31 360.00 $-5,640.81 0.00
2017-09-30 648.00 $-5,640.81 0.00
2017-06-30 2700.00 $-5,953.37 0.00
2017-03-31 6030.00 $-1,800.90 0.00
2016-12-31 2557.80 $-2,611.31 0.00
2016-09-30 2538.00 $-2,611.31 0.00
2016-06-30 4950.00 $-6,843.43 0.00
2016-03-31 5252.40 $-9,094.55 0.00
2015-12-31 9630.00 $-10,895.45 0.00
2015-09-30 8308.80 $-17,828.92 0.00
2015-06-30 15030.00 $-13,326.67 0.00
2015-03-31 12960.00 $-15,757.89 0.00
2014-12-31 18090.00 $-17,918.97 0.00
2014-09-30 33930.00 $-11,435.72 0.00
2014-06-30 33660.00 $-17,471.34 0.00
2014-03-31 41220.00 $-15,581.69 0.00
2013-12-31 49680.00 $-14,502.88 0.00
2013-09-30 41040.00 $-17,295.57 0.00
2013-06-30 43200.00 $-15,133.63 0.00
2013-03-31 43200.00 $-12,971.68 0.00
2012-12-31 65880.00 $-14,052.65 0.00
2012-09-30 102599.99 $-10,809.73 0.00
2012-06-30 97200.00 $-9,728.76 0.00
2012-03-31 129599.99 $-22,700.44 0.00
2011-12-31 139319.99 $-23,781.41 0.00
2011-09-30 139319.99 $-25,943.36 0.00
2011-06-30 188999.99 $-24,862.38 0.00
2011-03-31 95040.00 $-12,971.68 0.00
2010-12-31 71280.00 $-7,566.81 0.00
2010-09-30 43200.00 $-5,404.87 0.00
2010-06-30 52920.00 $-4,323.89 0.00
2010-03-31 92880.00 $-3,242.92 0.00
2009-12-31 74520.00 $-4,323.89 0.00
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.009B $0.015B
Precipio Inc. has built a platform designed to eradicate the problem of misdiagnosis by harnessing the intellect, expertise and technology developed within academic institutions and delivering quality diagnostic information to physicians and their patients worldwide. Through its collaborations with world-class academic institutions specializing in cancer research, diagnostics and treatment, Precipio offers a new standard of diagnostic accuracy enabling the highest level of patient care. Precipio Inc., formerly known as Transgenomic Inc., is based in Omaha, United States of America.
Stock Name Country Market Cap PE Ratio
Tempus AI (TEM) United States $8.497B 0.00
Inspire Medical Systems (INSP) United States $5.276B 164.53
Hims & Hers Health (HIMS) United States $5.141B 130.72
Privia Health (PRVA) United States $2.533B 211.10
Enovis (ENOV) United States $2.529B 17.15
IRhythm Technologies (IRTC) United States $2.362B 0.00
Azenta (AZTA) United States $2.001B 99.78
Omnicell (OMCL) United States $1.964B 64.26
Clover Health Investments (CLOV) United States $1.644B 0.00
10x Genomics (TXG) United States $1.643B 0.00
Schrodinger (SDGR) United States $1.378B 0.00
Phreesia (PHR) United States $1.072B 0.00
Butterfly Network (BFLY) United States $0.650B 0.00
Standard BioTools (LAB) United States $0.562B 0.00
Talkspace (TALK) United States $0.522B 0.00
Fulgent Genetics (FLGT) United States $0.520B 0.00
Definitive Healthcare (DH) United States $0.483B 83.60
Health Catalyst (HCAT) United States $0.459B 0.00
TruBridge (TBRG) United States $0.244B 71.22
Pulmonx (LUNG) United States $0.237B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.214B 0.00
American Well (AMWL) United States $0.122B 0.00
EUDA Health Holdings (EUDA) Singapore $0.107B 0.00
P3 Health Partners (PIII) United States $0.075B 0.00
HeartBeam (BEAT) United States $0.067B 0.00
111 (YI) China $0.053B 0.00
CareCloud (CCLD) United States $0.046B 0.00
Zepp Health (ZEPP) China $0.040B 0.00
SHL Telemedicine (SHLT) Israel $0.040B 0.00
Outset Medical (OM) United States $0.039B 0.00
Movano (MOVE) United States $0.020B 0.00
Bullfrog AI Holdings (BFRG) United States $0.019B 0.00
Streamline Health Solutions (STRM) United States $0.014B 0.00
Strata Skin Sciences (SSKN) United States $0.013B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.012B 0.00
MSP Recovery (LIFW) United States $0.010B 0.00
Healthcare Triangle (HCTI) United States $0.006B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.006B 0.00
Predictive Oncology (POAI) United States $0.004B 0.00
Syra Health (SYRA) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.002B 0.00
Zhongchao (ZCMD) China $0.002B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00